Drug information for HALOBETASOL PROPIONATE

Form Dosage Status Therapeutic Equivalence Active Ingred Ref. Sponsor Document
CREAM; TOPICAL 0.05% Prescription AB  HALOBETASOL PROPIONATE halobetasol FOUGERA PHARMS 77001
2004-12-30 Letter
CREAM; TOPICAL 0.05% Prescription AB  HALOBETASOL PROPIONATE halobetasol PERRIGO ISRAEL 77123
2004-12-23 Letter
CREAM; TOPICAL 0.05% Prescription AB  HALOBETASOL PROPIONATE halobetasol TARO 77227
CREAM; TOPICAL 0.05% Prescription AB  HALOBETASOL PROPIONATE halobetasol G AND W LABS 78162
OINTMENT; TOPICAL 0.05% Prescription AB  HALOBETASOL PROPIONATE halobetasol PERRIGO 76872
2004-12-30 Letter
OINTMENT; TOPICAL 0.05% Prescription AB  HALOBETASOL PROPIONATE halobetasol FOUGERA PHARMS 76903
2004-12-30 Letter
OINTMENT; TOPICAL 0.05% Prescription AB  HALOBETASOL PROPIONATE halobetasol TARO 76994
2004-12-30 Letter
OINTMENT; TOPICAL 0.05% Discontinued   HALOBETASOL PROPIONATE halobetasol ACTAVIS MID ATLANTIC 77109
OINTMENT; TOPICAL 0.05% Prescription AB  HALOBETASOL PROPIONATE halobetasol G AND W LABS 77721

Drug Adverse Effects information for HALOBETASOL PROPIONATE

Role code Indications Reaction # Reports
C ACNE CHOLECYSTITIS CHRONIC 2
C ACNE HEPATIC NECROSIS 2
C ACNE HEPATIC STEATOSIS 2
C ACNE HEPATOMEGALY 2
C ACNE INJURY 2
C ACNE MENTAL DISORDER 2
C ACNE PAIN 2
C ACNE SPLENOMEGALY 2
C PREMENSTRUAL SYNDROME CHOLECYSTITIS CHRONIC 2
C PREMENSTRUAL SYNDROME HEPATIC NECROSIS 2
C PREMENSTRUAL SYNDROME HEPATIC STEATOSIS 2
C PREMENSTRUAL SYNDROME HEPATOMEGALY 2
C PREMENSTRUAL SYNDROME INJURY 2
C PREMENSTRUAL SYNDROME MENTAL DISORDER 2
C PREMENSTRUAL SYNDROME PAIN 2
C PREMENSTRUAL SYNDROME SPLENOMEGALY 2
Ads by Google